Pharmazz Gains FDA Orphan Designation for Sovateltide in NHIE
WILLOWBROOK, Ill. — September 14, 2026 Pharmazz, Inc. announced that the U.S. Food and Drug Administration (FDA) Office of...
Acute Ischemic Stroke
Advertisement
Apollo Therapeutics Reports Positive APL-10456 Phase 1 Data
BOSTON, U.S. & CAMBRIDGE, U.K. — August 25, 2026 Apollo Therapeutics announced positive immunogenicity and cross-species activity data from...
BioCryst Wins Japan Approval for Pediatric ORLADEYO
TOKYO, Japan — August 25, 2026 BioCryst Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
Basking Biosciences Reports Positive Phase 1 Data for BB-025
RESEARCH TRIANGLE, North Carolina — August 25, 2026 Basking Biosciences announced positive topline Phase 1 data for BB-025, an...
CREATE Launches First Human Trial of In Vivo CAR-T Therapy
CAMBRIDGE, Mass., July 30, 2026 CREATE Medicines has received Human Research Ethics Committee (HREC) approval in Australia to initiate...
Advertisements
Basking Reports BB-031 Stroke Therapy Preclinical Breakthrough
RESEARCH TRIANGLE, N.C., July 30, 2026 Basking Biosciences has announced the publication of groundbreaking preclinical research in Communications Biology,...
Penumbra THUNDERBOLT Shows Strong Stroke Trial Results
ALAMEDA, California, July 22, 2026 Penumbra, Inc. has announced positive results from the THUNDER Investigational Device Exemption (IDE) study,...
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgAN
BRISBANE, Calif., July 7, 2026 Vera Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
Francis Medical Achieves California Vanquish Milestone
MAPLE GROVE, Minn., July 7, 2026 Francis Medical has announced that Orange County Urology Associates (OCUA) has become the...
Akston Reports Positive Canine Osteoarthritis Study Results
BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...
Advertisement
